Skip to content
Open access

Integrating Target Prediction and Transcriptomic Analysis Identifies the AKR1C2-KRT8 Axis in Rotenone-Induced Dopaminergic Neuron Injury.

Sep 2026 · Brain Research Bulletin · pp. 112106 · 0 citations · 45 references
Medicine

TL;DR

KRT8 re‑expression reversed the protective effects of AKR1C2 knockdown, while KRT8 knockdown reversed AKR1C2 overexpression‑induced impairments, collectively confirming the causal role of the AKR1C2-KRT8 axis.

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disorder in which environmental toxins play a critical etiological role. Rotenone, a classical mitochondrial complex I inhibitor used to model PD, exerts its neurotoxicity through incompletely defined downstream molecular networks. Here, we integrated multiple PD transcriptomic datasets from GEO with predicted rotenone targets, applied machine learning to screen core candidate genes, and analyzed their cellular localization using single-cell transcriptomics. Molecular docking was performed to assess target-rotenone binding, and functional validation was carried out in primary dopaminergic neurons via lentivirus-mediated gene manipulation, Western blotting, qRT-PCR, and mitochondrial function assays. This approach identified and validated a six-gene core network (AKR1C2, AKR1C3, CES1, CTSS, DRD2, HSPA1A), several of which were predicted to directly bind rotenone. Single-cell analysis confirmed their enrichment in PD dopaminergic neurons, and immunofluorescence validated their co-localization with the dopaminergic marker TH. In rotenone-treated neurons, all six genes except DRD2, as well as KRT8, were significantly upregulated at both the mRNA and protein levels; rotenone also impaired mitochondrial Complex I activity and ATP production, and increased α-synuclein expression. In silico knockout revealed that AKR1C2-perturbed genes were enriched in keratinization pathways. Functional experiments demonstrated that AKR1C2 positively regulates KRT8. Notably, AKR1C2 knockdown not only reduced KRT8 levels but also rescued mitochondrial function, neuronal viability, and rotenone-impaired action potential firing, whereas AKR1C2 overexpression exacerbated these deficits. Critically, KRT8 re‑expression reversed the protective effects of AKR1C2 knockdown, while KRT8 knockdown reversed AKR1C2 overexpression‑induced impairments, collectively confirming the causal role of the AKR1C2-KRT8 axis. Collectively, these findings delineate a multi-node molecular network downstream of rotenone and provide the first experimental validation of a novel AKR1C2-KRT8 regulatory axis in dopaminergic neuron injury.

Read PDF

Similar papers

Open access Sep 2026

Integrative transcriptomic analysis reveals KLHL2 downregulation as a potential driver of microglial inflammation in Alzheimer’s disease via the WNK3/JNK/c-Jun axis

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by prominent neuroinflammation. Microglia, the resident immune cells of the central nervous system, play a key role in AD-associated neuroinflammation, yet the molecular mechanisms regulating their inflammatory activation remain incomple...

Yao Yang, Cong-Hui Dai, Zong-Tang Xu et al. · 0 citations
Open access Sep 2026

Identification of Key Genes and Pathways in Parkinson’s Disease Through Bioinformatics Analysis

Integrative transcriptomics identified conserved central-peripheral signatures in PD and five hub genes are candidate biomarkers/therapeutic targets, offering a systems-level framework for disease mechanisms and independent cohort validation.

Ehsan Lotfi, Arsh Ketabforoush, Fereshteh Azeditehrani et al. · 0 citations
Open access Sep 2026

A neuron-distributed DEK integrates ac4C modification and neuroinflammation in pathogenesis of Parkinson disease: evidence from Mendelian randomization, multi-omics and in vitro validation

This study establishes a novel AN-associated molecular patterns in PD, identifying DEK as a computationally identified neuron-specific factor associated with ac4C modification and neuroinflammatory cascades for PD patients.

Yuan Li · 0 citations
Open access Aug 2026

Integrative transcriptomic and machine learning analyses identify NOL7 and TXLNA as candidate blood biomarkers for Parkinson’s disease within an RNA modification-associated co-expression network

Parkinson’s disease (PD) pathogenesis involves complex molecular mechanisms, with emerging evidence implicating RNA modifications (RM). This study sought to explore RM-associated key genes and their roles in PD progression. Transcriptomic datasets GSE6613 (training) and GSE72267 (validation) were analyze...

Mei-Ling Chen, Peng Chen, Liya Suo et al. · 0 citations
Open access Sep 2026

Cuproptosis-associated genes DLD, ULK2, CCL8, and CCS link metabolic and immunological dysfunction in Parkinson’s disease: a multi-omics study

It is suggested that dysregulation of cuproptosis-associated hub genes is associated with cell-type-specific pathological alterations in PD, rather than demonstrating a direct causal or synergistic regulatory mechanism.

Jing Wang, Ya-Hui Hu, Bo Wang et al. · 0 citations
Aug 2026

Transcriptomic profiling and structural characterization reveal UQCRC1 and COX4I1 as key mitochondrial regulators associated with oxidative stress in multiple sclerosis.

It is demonstrated that mitochondrial respiratory chain-related pathways, particularly those involving complexes III and IV, are consistently associated with the transcriptomic alterations observed in multiple sclerosis, providing evidence that mitochondrial bioenergetics and redox homeostasis may contribute to MS path...

Tatyana Tarkina, D. Azanbayeva, T. Algazina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.